- Home
- ACRV vs HPAI Comparison
ACRV vs HPAI Comparison
Compare ACRV & HPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- HPAI
- Stock Information
- Founded
- ACRV 2018
- HPAI 2023
- Country
- ACRV United States
- HPAI Singapore
- Employees
- ACRV N/A
- HPAI N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- HPAI
- Sector
- ACRV Health Care
- HPAI
- Exchange
- ACRV Nasdaq
- HPAI NYSE
- Market Cap
- ACRV 247.8M
- HPAI 234.3M
- IPO Year
- ACRV 2022
- HPAI N/A
- Fundamental
- Price
- ACRV $6.44
- HPAI $5.60
- Analyst Decision
- ACRV Strong Buy
- HPAI
- Analyst Count
- ACRV 5
- HPAI 0
- Target Price
- ACRV $22.40
- HPAI N/A
- AVG Volume (30 Days)
- ACRV 46.9K
- HPAI 36.0K
- Earning Date
- ACRV 11-13-2024
- HPAI 11-26-2024
- Dividend Yield
- ACRV N/A
- HPAI N/A
- EPS Growth
- ACRV N/A
- HPAI N/A
- EPS
- ACRV N/A
- HPAI N/A
- Revenue
- ACRV N/A
- HPAI $29,575,625.00
- Revenue This Year
- ACRV N/A
- HPAI N/A
- Revenue Next Year
- ACRV N/A
- HPAI N/A
- P/E Ratio
- ACRV N/A
- HPAI $27.66
- Revenue Growth
- ACRV N/A
- HPAI 132.36
- 52 Week Low
- ACRV $3.19
- HPAI $3.07
- 52 Week High
- ACRV $11.90
- HPAI $14.74
- Technical
- Relative Strength Index (RSI)
- ACRV 31.95
- HPAI N/A
- Support Level
- ACRV $6.11
- HPAI N/A
- Resistance Level
- ACRV $8.35
- HPAI N/A
- Average True Range (ATR)
- ACRV 0.48
- HPAI 0.00
- MACD
- ACRV -0.23
- HPAI 0.00
- Stochastic Oscillator
- ACRV 12.55
- HPAI 0.00
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About HPAI HELPORT AI LTD
Helport AI Ltd is a AI technology company based in Singapore dedicated to serving enterprises' customer contact centers with intelligent products, solutions, and a digital platform. Its software, Helport AI Assist (AI Assist), provides tailored AI-powered guidance and oversight for contact center interactions and customer experience, with functions including Agent Assistant, Quality Assurance (QA) Assistant, Supervisor Assistant, and Knowledge Base Assistant.